Literature DB >> 14500758

SNF2-related CBP activator protein (SRCAP) functions as a coactivator of steroid receptor-mediated transcription through synergistic interactions with CARM-1 and GRIP-1.

M Alexandra Monroy1, Natalie M Schott, Linda Cox, J Don Chen, Mary Ruh, John C Chrivia.   

Abstract

SRCAP (SNF2-related CBP activator protein) is a 350-kDa protein that shares homology with the SNF2 family of proteins whose members function in various aspects of transcriptional regulation. In various cell types, SRCAP is found in distinct multiprotein complexes that include proteins found in SWI/SNF chromatin remodeling complexes. SRCAP was identified by its ability to bind to CBP and was found to potentiate the ability of CBP to activate transcription. Studies in our laboratory have demonstrated that SRCAP functions as a coactivator for CREB-mediated transcription of a number of promoters, including that of the phosphoenolpyruvate carboxykinase gene. Our current studies demonstrate that SRCAP enhances phosphoenolpyruvate carboxykinase promoter transcription induced by glucocorticoids. SRCAP also enhances glucocorticoid receptor-mediated transcription of a simple promoter containing only two glucocorticoid response elements, indicating that SRCAP functions as a glucocorticoid receptor coactivator. In similar studies, SRCAP was also found to serve as a coactivator for the androgen receptor. SRCAP exhibits synergistic activation with nuclear receptor coactivators and functionally interacts in vivo with glucocorticoid receptor-interacting protein-1 and coactivator-associated arginine methyltransferase-1. We propose that SRCAP, by virtue of its ability to interact with CBP, functions as a coactivator to regulate transcription initiated by several signaling pathways.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14500758     DOI: 10.1210/me.2003-0208

Source DB:  PubMed          Journal:  Mol Endocrinol        ISSN: 0888-8809


  17 in total

1.  Trans-ancestry mutational landscape of hepatocellular carcinoma genomes.

Authors:  Yasushi Totoki; Kenji Tatsuno; Kyle R Covington; Hiroki Ueda; Chad J Creighton; Mamoru Kato; Shingo Tsuji; Lawrence A Donehower; Betty L Slagle; Hiromi Nakamura; Shogo Yamamoto; Eve Shinbrot; Natsuko Hama; Megan Lehmkuhl; Fumie Hosoda; Yasuhito Arai; Kim Walker; Mahmoud Dahdouli; Kengo Gotoh; Genta Nagae; Marie-Claude Gingras; Donna M Muzny; Hidenori Ojima; Kazuaki Shimada; Yutaka Midorikawa; John A Goss; Ronald Cotton; Akimasa Hayashi; Junji Shibahara; Shumpei Ishikawa; Jacfranz Guiteau; Mariko Tanaka; Tomoko Urushidate; Shoko Ohashi; Naoko Okada; Harsha Doddapaneni; Min Wang; Yiming Zhu; Huyen Dinh; Takuji Okusaka; Norihiro Kokudo; Tomoo Kosuge; Tadatoshi Takayama; Masashi Fukayama; Richard A Gibbs; David A Wheeler; Hiroyuki Aburatani; Tatsuhiro Shibata
Journal:  Nat Genet       Date:  2014-11-02       Impact factor: 38.330

2.  Histone-modifying complexes regulate gene expression pertinent to the differentiation of the protozoan parasite Toxoplasma gondii.

Authors:  Nehmé Saksouk; Micah M Bhatti; Sylvie Kieffer; Aaron T Smith; Karine Musset; Jérôme Garin; William J Sullivan; Marie-France Cesbron-Delauw; Mohamed-Ali Hakimi
Journal:  Mol Cell Biol       Date:  2005-12       Impact factor: 4.272

3.  NXP-2 association with SUMO-2 depends on lysines required for transcriptional repression.

Authors:  Adam Rosendorff; Shuhei Sakakibara; Sixin Lu; Elliott Kieff; Yan Xuan; Alessandra DiBacco; Yujiang Shi; Yang Shi; Grace Gill
Journal:  Proc Natl Acad Sci U S A       Date:  2006-03-27       Impact factor: 11.205

4.  Purification and assay of the human INO80 and SRCAP chromatin remodeling complexes.

Authors:  Yong Cai; Jingji Jin; Aaron J Gottschalk; Tingting Yao; Joan W Conaway; Ronald C Conaway
Journal:  Methods       Date:  2006-12       Impact factor: 3.608

5.  Proteomic analyses to identify novel therapeutic targets for the treatment of advanced prostate cancer.

Authors:  Barbara Comuzzi; Marianne D Sadar
Journal:  Cellscience       Date:  2006-07-27

6.  Mutations in SRCAP, encoding SNF2-related CREBBP activator protein, cause Floating-Harbor syndrome.

Authors:  Rebecca L Hood; Matthew A Lines; Sarah M Nikkel; Jeremy Schwartzentruber; Chandree Beaulieu; Małgorzata J M Nowaczyk; Judith Allanson; Chong Ae Kim; Dagmar Wieczorek; Jukka S Moilanen; Didier Lacombe; Gabriele Gillessen-Kaesbach; Margo L Whiteford; Caio Robledo D C Quaio; Israel Gomy; Debora R Bertola; Beate Albrecht; Konrad Platzer; George McGillivray; Ruobing Zou; D Ross McLeod; Albert E Chudley; Bernard N Chodirker; Janet Marcadier; Jacek Majewski; Dennis E Bulman; Susan M White; Kym M Boycott
Journal:  Am J Hum Genet       Date:  2012-01-19       Impact factor: 11.025

Review 7.  Constitutional Epi/Genetic Conditions: Genetic, Epigenetic, and Environmental Factors.

Authors:  Laila C Schenkel; David Rodenhiser; Victoria Siu; Elizabeth McCready; Peter Ainsworth; Bekim Sadikovic
Journal:  J Pediatr Genet       Date:  2016-11-08

8.  Regulation of androgen-responsive transcription by the chromatin remodeling factor CHD8.

Authors:  Tushar Menon; Joel A Yates; Daniel A Bochar
Journal:  Mol Endocrinol       Date:  2010-03-22

9.  Enzymatic activity is required for the in vivo functions of CARM1.

Authors:  Daehoon Kim; Jaeho Lee; Donghang Cheng; Jia Li; Carla Carter; Ellen Richie; Mark T Bedford
Journal:  J Biol Chem       Date:  2009-11-05       Impact factor: 5.157

10.  Protein arginine methyltransferase 6 regulates multiple aspects of gene expression.

Authors:  Matthew J Harrison; Yue Hang Tang; Dennis H Dowhan
Journal:  Nucleic Acids Res       Date:  2010-01-04       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.